Company Overview: Oculus

Industry News

5 Dec

Oculus Innovative Sciences Announces Corporate Name Change to Sonoma Pharmaceuticals, Inc. and New NASDAQ Ticker Symbol to Better Align with Dermatology Focus

PETALUMA, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that on December 6, 2016, it will officially change the name of...

Read more

30 Aug

Oculus Innovative Sciences Launches Lasercyn™ into U.S. Dermatology Market for Use Following Laser Procedures, Microdermabrasions and Chemical Peels

PETALUMA, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced the commercial launch into the U.S. dermatology market of the company’s newest...

Read more

6 Jul

Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data

May 2016: Highest Monthly Prescriptions Filled in Oculus’ History Quarter Ended March 31, 2016: Highest Quarterly Number of Prescriptions 34% over prior December quarter 25% average “quarter over quarter” growth in number of prescriptions for last four quarters PETALUMA, Calif., July 06, 2016 (GLOBE NEWSWIRE) — Oculus Innovative Sciences,...

Read more

22 Jun

Oculus Innovative Sciences Announces Reverse Split of Common Stock

Focus on Continued Growth in U.S. Dermatology Market While Expanding Potential Institutional Investor Base PETALUMA, Calif., June 22, 2016 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and...

Read more

28 Apr

Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City

Oculus Presentation on Thursday, May 5, 2016 at 2:00 pm EDT PETALUMA, Calif., April 28, 2016 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that Robert...

Read more

20 Apr

Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn™ for Use Following Laser Procedures, Microdermabrasions and Chemical Peels

PETALUMA, Calif., April 20, 2016 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced it has received a new 510(k) clearance from the U.S. Food and Drug...

Read more

Page 1 of 3123

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address